To the articles

USP Reference Standards – Standards of the United States Pharmacopeia
USP reference standards are the global quality benchmark for the analytical validation of pharmaceuticals, biologics, and excipients. Manufacturers of APIs, generics, complex biologics, or pharmaceutical raw materials require comparator substances that regulatory authorities and international pharmacopoeias fully trust.
As an authorized USP specialist retailer, we exclusively deliver standards – with the highest product safety, reliable supply chains and valid results for maximum patient safety.
The range of USP reference standards
Our portfolio includes thousands of USP standards , including:
✔ Drug active ingredient standards (APIs)
✔ Excipient standards
✔ Impurities & Degradation Products
✔ Nitrosamine standards
✔ Pharmaceutical Analytical Impurities (PAI)
✔ Analytical Reference Materials (ARM)
✔ Biologics Standards
✔ Compendial reagents
✔ Dissolution Performance Verification Standards (DPVS)
USP Pharmaceutical Analytical Impurities
READ MOREUSP Biologics
READ MOREUSP Analytical Reference Materials
READ MORE| Order no. | Article name | Batch number | CAS Number | Unit Price € | Quantity |
|---|---|---|---|---|---|
|
USP-1156167
Sale price140,21 €
|
Cyclopentylpropanoic Acid (25 mg) (3-Cyclopentylpropanoic acid) |
F094P0 | 140-77-2 | 140,21 € | |
|
USP-1157013
Sale price1.107,68 €
|
Cyclophosphamide Related Compound A (25 mg) (bis(2-chloroethyl)amine hydrochloride) |
R165K0 | 821-48-7 | 1.107,68 € | |
|
USP-1157024
Sale price1.086,65 €
|
Cyclophosphamide Related Compound B (25 mg) (3-(2-chloroethyl)-2-oxo-2-hydroxy-1,3,6,2-oxadiazaphosphonanes) |
R168H0 | 158401-52-6 | 1.086,65 € | |
|
USP-1157035
Sale price1.118,20 €
|
Cyclophosphamide Related Compound C (25 mg) (3-aminopropyl dihydrogen phosphate) |
R116R0 | 1071-28-9 | 1.118,20 € | |
|
USP-1157046
Sale price1.128,72 €
|
Cyclophosphamide Related Compound D (25 mg) (3-[2-(2-chloroethylamino)ethylamino]propyl dihydrogen phosphate dihydrochloride) |
R127N0 | 158401-51-5 | 1.128,72 € | |
|
USP-1158650
Sale price1.070,29 €
|
Cyclosporine Resolution Mixture (25 mg) (This material is an approximate 100:1 (w/w) mixture of cyclosporine and cyclosporine U) |
R172V0 | N/A | 1.070,29 € | |
|
USP-1161010
Sale price1.076,14 €
|
Cyproheptadine Related Compound A (40 mg) (5H-dibenzo[a,d]cycloheptene) |
R128R0 | 256-81-5 | 1.076,14 € | |
|
USP-1161032
Sale price1.108,85 €
|
Cyproheptadine Related Compound C (25 mg) (5-(1-methyl-piperidin-4-yl)-5H-dibenzo[a,d]cyclohepten-5-ol) |
R078J0 | 3967-32-6 | 1.108,85 € | |
|
USP-1162240
Sale price923,07 €
|
Dabigatran Etexilate Related Compound A (15 mg) (Ethyl 3-(2-{[(4-{[(hexyloxy)carbonyl]carbamoyl}phenyl)amino]methyl}-1-methyl-N-(pyridin-2-yl)-1H-benzimidazole-5-carboxamido)propanoate) |
F181N0 | 1408238-40-3 | 923,07 € | |
|
USP-1162251
Sale price923,07 €
|
Dabigatran Etexilate Related Compound B (15 mg) (Ethyl 3-(2-(((4-carbamimidoylphenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzimidazole-5-carboxamido)propanoate 4-toluenesulfonate) |
F23380 | 872728-85-3 | 923,07 € | |
|
USP-1162262
Sale price923,07 €
|
Dabigatran Etexilate Related Compound C (15 mg) (Ethyl 3-(2-{[(4-{N'-[(2-ethylbutoxy)carbonyl]carbamimidoyl}phenyl)amino]methyl}-1-methyl-N-(pyridin-2-yl)-1H-benzimidazole-5-carboxamido)propanoate) |
F181U0 | 1873316-01-8 | 923,07 € | |
